Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial 2025-01-20 21:50
SIRPAD - WORLD'S LARGEST RCT INVESTIGATING MAGICTOUCH PTA SIROLIMUS COATED BALLOON COMPLETES PATIENT ENROLMENT 2025-01-20 21:44
MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function 2025-01-18 08:30
Hanwha Life Launches 'Mobile Family Center' in Indonesia to Strengthen Community-Centered Mental Health Support for Women and Children 2025-01-17 21:00
Senaparib Approved by NMPA for 1L Maintenance Therapy in Ovarian Cancer 2025-01-17 10:56
New study highlights effectiveness and cost benefits of Myriad™ in lower limb salvage surgeries. 2025-01-17 10:08
Innovent and ASK Pharm Jointly Announce NMPA Approval of Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer 2025-01-17 08:00
LOTTE BIOLOGICS to Present at the 2025 J.P. Morgan Healthcare Conference 2025-01-17 07:11
Innovent Presents at the 43rd Annual J.P. Morgan Healthcare Conference 2025-01-17 07:00
Illuccix® Receives European Approval 2025-01-17 06:14
Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States 2025-01-17 03:15
Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering 2025-01-17 03:10
New NCCN Patient Resource Shares Latest Understanding of Genetic Testing to Guide Patient Decision Making 2025-01-16 21:07
SEACare 2025 - Your Gateway to Southeast Asia's Thriving Healthcare Market and Strategic Connections 2025-01-16 19:56
BioWorld by Clarivate Releases Comprehensive 2024 Year in Review 2025-01-16 16:00
BGI Genomics Empowers Brunei's National Cervical Cancer Prevention Program 2025-01-16 12:51
Shanghai opens its doors to foreign-owned hospitals 2025-01-16 09:39
(Taiwan) CMU Healthcare System and Nobel Laureate Randy Schekman Drive New Frontiers in Exosome Technology 2025-01-16 09:00
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer 2025-01-16 08:03
IHS Passes Rigorous Audit for World-Wide Distribution of its Insignis™ Infusion System 2025-01-15 23:05
1 2 3 4 5 980